Close Menu

University of California

Off Their Boards

More than two dozen University of California researchers are taking a break from their positions on the editorial boards of Elsevier journals, according to ScienceInsider.

The US Patent and Trademark Office is opening another interference proceeding in the CRISPR patent fight.

The University of California has decided to not renew its subscription with the scientific publisher Elsevier.

Stat News reports that the University of California and publisher Elsevier are fighting over open-access journal payments.

In PNAS this week: germline variants influence tumor immune gene expression in two dozen cancer types, phylogenetic relationships of hemipteroid insects, and more.

Three studies encompassing dozens of ancient genomes are offering a closer look at complex historical population spread in North, Central, and South America.

A federal appeals court in the US has upheld a judgment that gave the Broad Institute key CRISPR patents.

Researchers used CRISPR to engineer mice that have multiple genetic variants associated with late-onset AD to facilitate research into biomarkers and treatments.

The technology behind Mammoth's platform bears a striking resemblance to the CRISPR-based SHERLOCK platform developed by researchers at the Broad Institute.

A lawyer and a scientist say the best result in the CRISPR patent fight would be narrow patents that prevent anyone from controlling downstream innovation.

Pages

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.